Vectura Group (VEC) Pharma and Biotech Sector

  • Latest quote

    100.00p (mid)

  • Current Change (%)

    0.20%

  • Price

    Bid: 99.90p

    Offer: 100.10p

  • Today

    High: 100.40p

    Low: 98.95p

  • This year

    High: 163.00p

    Low: 89.95p

  • Information

    Volume: 1,904,381

    Market Cap: £679.68M


Vectura Group RNS Feed

Title Release date
Director/PDMR Shareholding 09:31 - October 10, 2017
Positive flutiform k-haler regulatory progress 16:03 - October 4, 2017
Vectura Group Employee Benefit Trust 13:59 - October 4, 2017
Voting Rights and Capital 09:34 - October 3, 2017
Director/PDMR Shareholding 09:43 - September 13, 2017
Mundipharma presents positive findings at ERS 2017 12:28 - September 12, 2017
Director/PDMR Shareholding 07:00 - September 12, 2017
Director's Share Purchase - Replacement 10:45 - September 8, 2017
Director's Share Purchase 09:28 - September 8, 2017
Director/PDMR Shareholding 16:12 - September 7, 2017
Interim Results 2017 07:03 - September 6, 2017
Vectura announces VR410 agreement with Pulmatrix 07:00 - September 6, 2017
Voting Rights and Capital 14:59 - September 1, 2017
Hikma statement on generic Advair Diskus® (VR315) 07:06 - August 17, 2017
Global development agreement with Dynavax 07:00 - August 16, 2017

NOTE: This is based on 26 open tips for this company


Total Number of Share tips :

26

View all Vectura Group Tips


Company overview

Vectura develops inhaled therapies principally for the treatment of respiratory diseases.

Daily share tips delivered straight to your pc, tablet & mobile

Join Free Today